182
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis

, , , , &
Pages 55-66 | Received 21 Apr 2011, Accepted 02 Aug 2011, Published online: 04 Oct 2011

References

  • Aliabadi HM, Elhasi S, Mahmud A, Gulamhusein R, Mahdipoor P, Lavasanifar A. (2007). Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: The effect of solvent composition on micellar properties and drug loading. Int J Pharm, 329, 158–165.
  • Aliabadi HM, Mahmud A, Sharifabadi AD, Lavasanifar A. (2005). Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. J Control Release, 104, 301–311.
  • Bae YH. (2009). Drug targeting and tumor heterogeneity. J Control Release, 133, 2–3.
  • Chiu CC, Li CH, Ung MW, Fuh TS, Chen WL, Fang K. (2005). Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells. Cancer Lett, 223, 249–258.
  • Dong Y, Feng SS. (2007). In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials, 28, 4154–4160.
  • Dua P, Gude RP. (2006). Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemother Pharmacol, 58, 195–202.
  • Dua P, Gude RP. (2008). Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. Eur J Cancer, 44, 1587–1595.
  • Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. (2004). Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res, 64, 7668–7672.
  • Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. (2006). Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release, 116, 139–149.
  • Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. (2006). Clonogenic assay of cells in vitro. Nat Protoc, 1, 2315–2319.
  • Freitas VM, Souza LG, Oliveira EC, Furuse C, Araujo VC, Jaeger RG. (2007). Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and β-catenin expression. Oral Oncol, 43, 987–98.
  • Gloe T, Pohl U. (2002). Laminin binding conveys mechanosensing in endothelial cells. News Physiol Sci, 17, 166–169.
  • Grzanka A. (2001). Estimation of changes in tubulin induced with etoposide in human leukemia cells line K-562 by immunofluorescence microscope. Neoplasma, 48, 48–51.
  • Grzanka A, Grzanka D. (2003). The influence of etoposide on the distribution of tubulin in human leukemia cell line HL-60. Med Sci Monit, 9, BR66–BR69.
  • Gu F, Zhang L, Teply BA, Mann N, Wang A, Radovic-Moreno AF, Langer R, Farokhzad OC. (2008). Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA, 105, 2586–2591.
  • Gude RP, Jadhav MG, Rao SG, Jagtap AG. (2002). Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm, 17, 183–192.
  • Hu Y, Zhang L, Cao Y, Ge H, Jiang X, Yang C. (2004). Degradation behavior of poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles in aqueous solution. Biomacromolecules, 5, 1756–1762.
  • Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. (2005). Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm, 296, 151–161.
  • Kang YH, Lee E, Youk HJ, Kim SH, Lee HJ, Park YG, Lim SJ. (2005). Potentiation by α-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells. Cancer Lett, 217, 181–190.
  • Kim MS, Seo KS, Khang G, Cho SH, Lee HB. (2004). Preparation of poly(ethylene glycol)-block-poly(caprolactone) copolymers and their applications as thermo-sensitive materials. J Biomed Mater Res A, 70, 154–158.
  • Kim MS, Hyun H, Cho YH, Seo KS, Jang WY, Kim SK, Khang G, Lee HB. (2005). Preparation of methoxy poly(ethylene glycol)-block poly(ϵ-caprolactone) via activated monomer mechanism and examination of micellar characterization. Pol Bull, 55, 149–56.
  • Koliakos G, Trontzos C, Kouzi-Koliakos K, Kanellaki M, Grammaticos P. (1997). Lung carcinoma imaging using a synthetic laminin derivative radioiodinated peptide YIGSR. J Nucl Med, 38, 1940–1944.
  • Lee H, Hu M, Reilly RM, Allen C. (2007). Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy. Mol Pharm, 4, 769–781.
  • Letchford K, Burt H. (2007). A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: Micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm, 65, 259–269.
  • Li X, Li R, Qian X, Ding Y, Tu Y, Guo R, Hu Y, Jiang X, Guo W, Liu B. (2008). Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm, 70, 726–734.
  • Licciardi M, Giammona G, Du J, Armes SP, Tang Y, Lewis AL. 2006. New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems. Polymer, 47, 2946–55.
  • Lin WJ, Wang CL, Chen YC. (2005). Comparison of two pegylated copolymeric micelles and their potential as drug carriers. Drug Deliv, 12, 223–227.
  • Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY. (2007). Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 28, 1423–1433.
  • Lopez-Barcons LA, Polo D, Reig F, Fabra A. (2004). Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes. J Biomed Mater Res A, 69, 155–163.
  • Luo L, Tam J, Maysinger D, Eisenberg A. (2002). Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles. Bioconjug Chem, 13, 1259–1265.
  • Mafune K, Ravikumar TS. (1992). Anti-sense RNA of 32-kDa laminin-binding protein inhibits attachment and invasion of a human colon carcinoma cell line. J Surg Res, 52, 340–346.
  • Mu Y, Kamada H, Kodaira H, Sato K, Tsutsumi Y, Maeda M, Kawasaki K, Nomizu M, Yamada Y, Mayumi T. (1999). Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life. Biochem Biophys Res Commun, 264, 763–767.
  • Nakada S, Katsuki Y, Imoto I, Yokoyama T, Nagasawa M, Inazawa J, Mizutani S. (2006). Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. J Clin Invest, 116, 80–89.
  • Nasongkla N, Shuai X, Ai H, Weinberg BD, Pink J, Boothman DA, Gao J. (2004). cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl, 116, 6483–87.
  • Noh T, Kook YH, Park C, Youn H, Kim H, Oh ET, Choi EK, Park HJ, Kim C. (2008). Block copolymer micelles conjugated with anti-EGFR antibody for targeted delivery of anticancer drug. J Polym Sci Part A: Polym Chem, 46, 7321–31.
  • Ratheesh A, Ingle A, Gude RP. (2007). Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther, 6, 1743–1752.
  • Sant VP, Nagarsenker MS, Rao SG, Gude RP. (2000). Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 melanoma model. J Pharm Pharmacol, 52, 1461–1466.
  • Satoh K, Narumi K, Abe T, Sakai T, Kikuchi T, Tanaka M, Shimo-Oka T, Uchida M, Tezuka F, Isemura M, Nukiwa T. (1999). Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells. Br J Cancer, 80, 1115–1122.
  • Savic R, Luo L, Eisenberg A, Maysinger D. (2003). Micellar nanocontainers distribute to defined cytoplasmic organelles. Science, 300, 615–618.
  • Shuai X, Ai H, Nasongkla N, Kim S, Gao J. (2004). Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release, 98, 415–426.
  • Snyder SL, Sobocinski PZ. (1975). An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem, 64, 284–288.
  • Sutton D, Nasongkla N, Blanco E, Gao J. (2007). Functionalized micellar systems for cancer targeted drug delivery. Pharm Res, 24, 1029–1046.
  • Sutton D, Wang S, Nasongkla N, Gao J, Dormidontova EE. (2007). Doxorubicin and β-lapachone release and interaction with micellar core materials: Experiment and modeling. Exp Biol Med (Maywood), 232, 1090–1099.
  • Tanaka M, Narumi K, Isemura M, Abe M, Sato Y, Abe T, Saijo Y, Nukiwa T, Satoh K. (2000). Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis. Cancer Lett, 153, 161–168.
  • Torchilin VP. (2007). Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res, 24, 1–16.
  • Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. (2003). Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA, 100, 6039–6044.
  • Upadhyay KK, Agrawal HG, Upadhyay C, Schatz C, Le Meins JF, Misra A, Lecommandoux S. (2009). Role of block copolymer nanoconstructs in cancer therapy. Crit Rev Ther Drug Carrier Syst, 26, 157–205.
  • Vande Broek I, Vanderkerken K, De Greef C, Asosingh K, Straetmans N, Van Camp B, Van Riet I. (2001). Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor. Br J Cancer, 85, 1387–1395.
  • Xiong XB, Mahmud A, Uludag H, Lavasanifar A. (2008). Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res, 25, 2555–2566.
  • Xiong XB, Mahmud A, Uludag H, Lavasanifar A. (2007). Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules, 8, 874–884.
  • Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm, 348, 137–145.
  • Zalipsky S, Mullah N, Harding JA, Gittelman J, Guo L, DeFrees SA. (1997). Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains. Bioconjug Chem, 8, 111–118.
  • Zeng F, Lee H, Allen C. (2006). Epidermal growth factor-conjugated poly(ethylene glycol)-block-poly(Δ-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. Bioconjug Chem, 17, 399–409.
  • Zhang Y, Li A, Wang Z, Han Z, He J, Ma J. (2008). Antimetastatic activities of pegylated liposomal doxorubicin in a murine metastatic lung cancer model. J Drug Target, 16, 679–687.
  • Zhao H, Yung LY. (2008). Selectivity of folate conjugated polymer micelles against different tumor cells. Int J Pharm, 349, 256–268.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.